Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma - Concepedia

Concepedia

Publication | Closed Access

Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma

99

Citations

24

References

2015

Year

Magdalena Klánová, Ladislav Anděra, Jan Bražina, Jan Švadlenka, Simona Benesova, J. Soukup, Dana Průková, Dana Vejmelkova, Radek Jakša, Karel Helman,

Clinical Cancer Research

Abstract

As homoharringtonine is a clinically approved antileukemia drug, and ABT-199 is in advanced phases of diverse clinical trials, our data might have direct implications for novel concepts of early clinical trials in patients with aggressive DLBCL.

References

	Year	Citations

Page 1